Literature DB >> 34359995

The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry.

Jared Kirui1,2, Yara Abidine3,4, Annasara Lenman1,3, Koushikul Islam3, Yong-Dae Gwon3, Lisa Lasswitz1,2, Magnus Evander3, Marta Bally3,4, Gisa Gerold1,2,3,4.   

Abstract

Chikungunya virus (CHIKV) is a re-emerging, mosquito-transmitted, enveloped positive stranded RNA virus. Chikungunya fever is characterized by acute and chronic debilitating arthritis. Although multiple host factors have been shown to enhance CHIKV infection, the molecular mechanisms of cell entry and entry factors remain poorly understood. The phosphatidylserine-dependent receptors, T-cell immunoglobulin and mucin domain 1 (TIM-1) and Axl receptor tyrosine kinase (Axl), are transmembrane proteins that can serve as entry factors for enveloped viruses. Previous studies used pseudoviruses to delineate the role of TIM-1 and Axl in CHIKV entry. Conversely, here, we use the authentic CHIKV and cells ectopically expressing TIM-1 or Axl and demonstrate a role for TIM-1 in CHIKV infection. To further characterize TIM-1-dependent CHIKV infection, we generated cells expressing domain mutants of TIM-1. We show that point mutations in the phosphatidylserine binding site of TIM-1 lead to reduced cell binding, entry, and infection of CHIKV. Ectopic expression of TIM-1 renders immortalized keratinocytes permissive to CHIKV, whereas silencing of endogenously expressed TIM-1 in human hepatoma cells reduces CHIKV infection. Altogether, our findings indicate that, unlike Axl, TIM-1 readily promotes the productive entry of authentic CHIKV into target cells.

Entities:  

Keywords:  Axl; Axl receptor tyrosine kinase; CHIKV; Chikungunya virus; T-cell immunoglobulin and mucin domain 1; TIM-1; alphavirus; entry; enveloped virus; phosphatidylserine

Year:  2021        PMID: 34359995     DOI: 10.3390/cells10071828

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  6 in total

Review 1.  A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.

Authors:  Thaise Yasmine Vasconcelos de Lima Cavalcanti; Mylena Ribeiro Pereira; Sergio Oliveira de Paula; Rafael Freitas de Oliveira Franca
Journal:  Viruses       Date:  2022-05-05       Impact factor: 5.818

Review 2.  Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.

Authors:  Sarawut Khongwichit; Jira Chansaenroj; Chintana Chirathaworn; Yong Poovorawan
Journal:  J Biomed Sci       Date:  2021-12-02       Impact factor: 8.410

3.  Scrambled or flipped: 5 facts about how cellular phosphatidylserine localization can mediate viral replication.

Authors:  Marissa Danielle Acciani; Melinda Ann Brindley
Journal:  PLoS Pathog       Date:  2022-03-04       Impact factor: 6.823

4.  Virus-Host Cell Interactions.

Authors:  Thomas Hoenen; Allison Groseth
Journal:  Cells       Date:  2022-02-25       Impact factor: 6.600

Review 5.  Genome-Wide Approaches to Unravel the Host Factors Involved in Chikungunya Virus Replication.

Authors:  Atsushi Tanaka; Youichi Suzuki
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

6.  miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections.

Authors:  Urna Kansakar; Jessica Gambardella; Fahimeh Varzideh; Roberta Avvisato; Stanislovas S Jankauskas; Pasquale Mone; Alessandro Matarese; Gaetano Santulli
Journal:  Int J Mol Sci       Date:  2022-09-06       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.